Taiho Pharmaceutical to Acquire Araris Biotech for USD 400 Million, Expanding ADC Portfolio
Japan-based Taiho Pharmaceutical Co., Ltd. announced plans to fully acquire Araris Biotech AG, a Swiss...
Araris Biotech
Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development
Switzerland-based oncology biotech Araris Biotech AG has announced a research collaboration and option to license...